Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety

March 14, 2007 updated by: Wyeth is now a wholly owned subsidiary of Pfizer

An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.

The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment

2560

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Belgium
- - Aarschot, Belgium, 3200
  - Aiseau-Presles, Belgium, 6250
  - Anderlues, Belgium, 6150
  - Andrimont, Belgium, 4821
  - Angleur, Belgium, 4031
  - Ans, Belgium, 4430
  - Anthée, Belgium, 5520
  - Auvelais, Belgium, 5060
  - Avelgem, Belgium, 8581
  - Beauraing, Belgium, 5570
  - Beernem, Belgium, 8730
  - Bekegem-Ichtegem, Belgium, 8480
  - Belgrade, Belgium, 5001
  - Bertogne, Belgium, 6687
  - Betekom, Belgium, 3130
  - Bierges, Belgium, 1301
  - Binche, Belgium, 7130
  - Bioul, Belgium, 5537
  - Braine l'Alleud, Belgium, 1420
  - Brugge, Belgium, 8000
  - Brugge, Belgium, 8200
  - Brussel, Belgium, 1130
  - Bruxelles, Belgium, 1050
  - Bruxelles, Belgium, 1200
  - Bruxelles, Belgium, 1180
  - Bruxelles, Belgium, 1090
  - Bruxelles, Belgium, 1040
  - Bruxelles, Belgium, 1080
  - Bruxelles, Belgium, 1083
  - Bruxelles, Belgium, 1140
  - Charleroi, Belgium, 6000
  - Ciney, Belgium, 5590
  - Couillet, Belgium, 6010
  - Deurne (Antwerpen), Belgium, 2100
  - Dworp, Belgium, 1653
  - Eghezée, Belgium, 5310
  - Eupen, Belgium, 4700
  - Galmaarden, Belgium, 1570
  - Goutroux, Belgium, 6030
  - Grimminge, Belgium, 9506
  - Hatrival, Belgium, 6870
  - Hemiksem, Belgium, 2620
  - Herenthout, Belgium, 2270
  - Hoboken, Belgium, 2660
  - Houdeng-Aimeries, Belgium, 7110
  - Houdeng-Goegnies, Belgium, 7110
  - Incourt, Belgium, 1315
  - Itegem, Belgium, 2222
  - Jabbeke, Belgium, 8490
  - Jambes, Belgium, 5100
  - Jodoigne, Belgium, 1370
  - Kapellen, Belgium, 2950
  - Kettenis, Belgium, 4701
  - Klemskerke, Belgium, 8420
  - Kuurne, Belgium, 8520
  - Laarne, Belgium, 9270
  - Lasne, Belgium, 1380
  - Leuven, Belgium, 3000
  - Lobbes, Belgium, 6540
  - Luttre, Belgium, 6238
  - Melin, Belgium, 1370
  - Merksem, Belgium, 2170
  - Monceau-sur-Sambre, Belgium, 6031
  - Morlanwelz, Belgium, 7140
  - Moustier S/S, Belgium, 5190
  - Noorderwijk, Belgium, 2200
  - Oudenaarde, Belgium, 9700
  - Ranst, Belgium, 2520
  - Reves, Belgium, 6312
  - Rixensart, Belgium, 1330
  - Romsee, Belgium, 4624
  - Rotselaar, Belgium, 3110
  - Ruddervoorde, Belgium, 8020
  - Sainte-Marie-sur-Semois, Belgium, 6740
  - Schildewindeke, Belgium, 9860
  - Schoten, Belgium, 2900
  - St-Joris Winge, Belgium, 3390
  - Steenokkerzeel, Belgium, 1820
  - Waarschoot, Belgium, 9950
  - Waha, Belgium, 6900
  - Walem, Belgium, 2800
  - Wavre, Belgium, 1300
  - Wetteren, Belgium, 9230
  - Wevelgem, Belgium, 8560
  - Wilrijk, Belgium, 2610
  - Wommelgem, Belgium, 2160
  - Wondelgem, Belgium, 9032
  - Wuustwezel-Gooreind, Belgium, 2990
  - Zelzate, Belgium, 9060
  - Zemst, Belgium, 1980
  - Zetrud-Lumay, Belgium, 1370

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Description

Inclusion Criteria:

Outpatient must be at least 18 years of age
Consulting a General Practitioner for painful physical symptoms
Written informed consent

Exclusion Criteria:

Patient is unable to understand and comply with procedures of the study
Patient is unable to complete the patient ratings
Patient has an acute pain with an obvious cause

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2005

Study Registration Dates

First Submitted

October 17, 2005

First Submitted That Met QC Criteria

October 17, 2005

First Posted (Estimate)

October 18, 2005

Study Record Updates

Last Update Posted (Estimate)

March 15, 2007

Last Update Submitted That Met QC Criteria

March 14, 2007

Last Verified

March 1, 2007

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

0600B1-102003

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.